Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
New York: Simon & Schuster
Diabetes Res
All treatments are administered by licensed clinicians in a professional setting focused on comfort and safety
20 mg in female arousal studies Subcutaneous injection: 0.75 mg, 1.25 mg, and 1.75 mg in Phase 2-3 female HSDD trials FDA-approved dose: 1.75 mg subcutaneously as needed, at least 45 minutes before sexual activity Important: These are doses from completed clinical trials
Theyll help you create a personalized transition plan, taking into account your current regimen, health history, and other factors
US$ 22.93
US$ 24.22
US$ 24.05
US$ 26.97
